Correlation Between Pfizer and 43118DAA8
Specify exactly 2 symbols:
By analyzing existing cross correlation between Pfizer Inc and US43118DAA81, you can compare the effects of market volatilities on Pfizer and 43118DAA8 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of 43118DAA8. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and 43118DAA8.
Diversification Opportunities for Pfizer and 43118DAA8
Excellent diversification
The 3 months correlation between Pfizer and 43118DAA8 is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and US43118DAA81 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US43118DAA81 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with 43118DAA8. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US43118DAA81 has no effect on the direction of Pfizer i.e., Pfizer and 43118DAA8 go up and down completely randomly.
Pair Corralation between Pfizer and 43118DAA8
Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.4 times more return on investment than 43118DAA8. However, Pfizer Inc is 2.53 times less risky than 43118DAA8. It trades about 0.17 of its potential returns per unit of risk. US43118DAA81 is currently generating about -0.13 per unit of risk. If you would invest 2,557 in Pfizer Inc on October 11, 2024 and sell it today you would earn a total of 129.00 from holding Pfizer Inc or generate 5.04% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 61.9% |
Values | Daily Returns |
Pfizer Inc vs. US43118DAA81
Performance |
Timeline |
Pfizer Inc |
US43118DAA81 |
Pfizer and 43118DAA8 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and 43118DAA8
The main advantage of trading using opposite Pfizer and 43118DAA8 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, 43118DAA8 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 43118DAA8 will offset losses from the drop in 43118DAA8's long position.Pfizer vs. Emergent Biosolutions | Pfizer vs. Bausch Health Companies | Pfizer vs. Neurocrine Biosciences | Pfizer vs. Teva Pharma Industries |
43118DAA8 vs. Cannae Holdings | 43118DAA8 vs. Westrock Coffee | 43118DAA8 vs. Monster Beverage Corp | 43118DAA8 vs. Willamette Valley Vineyards |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |